United States · FDA National Drug Code directory
Keppra
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-002_38cabb23-4e04-9a05-e063-6394a90a2a94
- Product NDC
- 50474-002
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- levetiracetam
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060823
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) / 5 mL in 1 VIAL, SINGLE-USE · 50474-002-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →